Publications (2019-)

Update 21-APR-2023

＊Corresponding author(s)

2023

  1. Chinatsu Kurasaka, Nana Nishizawa, Haruka Uozumi, Yoko Ogino, ＊Akira Sato. Relationship between anticancer sensitivity and cellular respiration property in 5-fluorouracil-resistant HCT116 human colorectal cancer cells. FEBS OpenBio, in press. https://doi.org/10.1002/2211-5463.13611. (IF=2.792 in 2021)
  2. Nagwa S. M. Aly, Hiroaki Matsumori, Thi Quyen Dinh, Akira Sato, Shin-Ich Miyoshi, Kyung-Soo Chang, Hak Sun Yu, Duc Tuan Cao, ＊Hye-Sook Kim. A pioneer use of antimalarial transdermal combination therapy in the rodent malaria model. Pathogens, 12(3), 398, 2023. https://doi.org/10.3390/pathogens12030398. (IF=4.531 in 2021)
  3. Nagwa S.M. Aly, Hiroaki Matsumori, Thi Quyen Dinh, Akira Sato, Shin-Ich Miyoshi, Kyung-Soo Chang, Hak Sun Yu, Fumie Kobayashi, ＊Hye-Sook Kim. Antimalarial effect of synthetic endoperoxide on synchronized Plasmodium chabaudi infected mice. Parasites, Hosts and Diseases, 61(1), 33-41, 2023. https://doi.org/10.3347/PHD.22119. (IF=1.776 in 2021)
  4. Nagwa S.M. Aly, Hiroaki Matsumori, Thi Quyen Dinh, Akira Sato, Shin-Ich Miyoshi, Kyung-Soo Chang, Hak Sun Yu, ＊Hye-Sook Kim. Formulation and evaluation of the antimalarial N-89 as a transdermal drug candidate. Parasitology International, 93, 102720, 2023. https://doi.org/10.1016/j.parint.2022.102720. (IF=2.106 in 2021)
  5. Nana Nishizawa, Chinatsu Kurasaka, Yoko Ogino, ＊Akira Sato. Regulation of 5-fluorodeoxyuridine monophosphate-thymidylate synthase ternary complex levels by autophagy confers resistance to 5-fluorouracil. FASEB BioAdvances,5(1), 43-51, 2023. https://doi.org/10.1096/fba.2022-00099. (IF=N.D., CiteScore= 3.9 in 2022)
  6. Kaede Tsuda, Chinatsu Kurasaka, Yoko Ogino, ＊Akira Sato. Genomic and biological aspects of resistance to selective poly(ADP-ribose) glycohydrolase inhibitor PDD00017273 in human colorectal cancer cells. Cancer Reports, 6(2), e1709, 2023. https://doi.org/10.1002/cnr2.1709 (IF=N.D., CiteScore=2.0 in 2022)

2022

  1. Chinatsu Kurasaka, Nana Nishizawa, Yoko Ogino, ＊Akira Sato. Trapping of 5-fluorodeoxyuridine monophosphate by thymidylate synthase confers resistance to 5-fluorouracil. ACS Omega, 7(7), 6046-6052, 2022. http://doi.org/10.1021/acsomega.1c06394 (IF= 4.132 in 2021)
  2. ＊Akira Sato, Nozomi Tagai, Yoko Ogino, Haruka Uozumi, Shinpei Kawakami, Takayuki Yamamoto, Sei-ichi Tanuma, Hiroko Maruki-Uchida, Sadao Mori, and Minoru Morita. Passion fruit seed extract protects beta-amyloid-induced neuronal cell death in a differentiated human neuroblastoma SH-SY5Y cell model. Food Science & Nutrition, 10(5), 1461-1468, 2022. http://doi.org/10.1002/fsn3.2757 (IF= 3.553 in 2021)

2021

  1. Natsumi Ogawa, Shingo Nakajima, Kenya Tamada, Natsuki Yokoue, Haruki Tachibana, Miwa Okazawa, Takahiro Oyama, Hideaki Abe, Hiroaki Yamazaki, Atsushi Yoshimori, Akira Sato, Takanori Kamiya, Takehiko Yokomizo, Fumiaki Uchiumi, Takehiko Abe, ＊Sei-ichi Tanuma. Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages. Archives of Biochemistry and Biophysics, 711, 109029, 2021. doi: https://doi.org/10.1016/j.abb.2021.109029 (IF=4.114 in 2021)
  2. ＊Akira Sato, Yoko Ogino, Sei-ichi Tanuma, Fumiaki Uchiumi. Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2. Nucleosides, Nucleotides & Nucleic Acids, 40:8, 790-797, 2021. doi: 10.1080/15257770.2021.1950759 (IF=1.449 in 2021)
  3. Chinatsu Kurasaka, Yoko Ogino, ＊Akira Sato. Molecular mechanisms and tumor biological aspects of 5-fluorouracil resistance in HCT116 human colorectal cancer cells. International Journal of Molecular Sciences, 22(6), 2916, 2021. https://doi.org/10.3390/ijms22062916. (IF=6.208 in 2021)
  4. ＊Kazumi Yoshizawa, Kota Takeuchi, Toka Nakamura, Saki Ukai, Yukino Takahashi, Akira Sato, Ryoko Takasawa, Sei‐ichi Tanuma. Antinociceptive activity of the novel RAGE inhibitor, papaverine, in a mouse model of chronic inflammatory pain. Synapse, 75, e22188, 2021. https://doi.org/10.1002/syn.22188 (IF-2.537 in 2021)

2020

  1. ＊Akira Sato, Akihiro Yamamoto, Akira Shimotsuma, Yoko Ogino, Naoki Funayama, Yui Takahashi, Akiko Hiramoto, Yusuke Wataya, Hye-Sook Kim. Intracellular microRNA expression patterns influence cell death fates for both necrosis and apoptosis. FEBS Open Bio,10(11), 2417-2426, 2020. https://doi.org/10.1002/2211-5463.12995. (IF=2.321, CiteScore=3.0 in 2019)
  2. Shingo Nakajima, Natsumi Ogawa, Natsuki Yokoue, Haruki Tachibana, Kenya Tamada, Miwa Okazawa, Akira Sato, Takahiro Oyama, Hideaki Abe, Takanori Kamiya, Atsushi Yoshimori, Kazumi Yoshizawa, Shigeaki Inoue, Takehiko Yokomizo, Fumiaki Uchiumi, Takehiko Abe, ＊Sei-ichi Tanuma. Trimebutine attenuates high mobility group box 1–receptor for advanced glycation end-products inflammatory signaling pathways. Biochemical and Biophysical Research Communications, 533(4), 1155-1161, 2020. https://doi.org/10.1016/j.bbrc.2020.09.126. (IF=2.985, CiteScore=4.6 in 2019)
  3. ＊Akira Sato, Akiko Hiramoto, Hye-Sook Kim, Yusuke Wataya. Anticancer Strategy Targeting Cell Death Regulators: Switching the Mechanism of Anticancer Floxuridine-Induced Cell Death from Necrosis to Apoptosis. The International Journal of Molecular Sciences, 21(16), 5876, 2020. doi: 10.3390/ijms21165876 (IF=5.923 in 2020, CiteScore=5.3 in 2019) Review article
  4. ＊Sei-ichi Tanuma, Kiyotaka Katsuragi, Takahiro Oyama, Atsushi Yoshimori, Yuri Shibasaki, Yasunobu Asawa, Hiroaki Yamazaki, Kosho Makino, Miwa Okazawa, Yoko Ogino, Yoshimi Sakamoto, Miyuki Nomura, Akira Sato, Hideaki Abe, Hiroyuki Nakamura, Hideyo Takahashi, Nobuhiro Tanuma, Fumiaki Uchiumi. Structural basis of beneficial design for effective nicotinamide phosphoribosyltransferase inhibitors. Molecules, 25(16), 3633, 2020. doi: 10.3390/molecules25163633. (IF=3.267, CiteScore=4.1 in 2019)
  5. #Nozomi Tagai, #Ayako Tanaka, ＊Akira Sato, Fumiaki Uchiumi, ＊Sei-ichi Tanuma. Low levels of brain-derived neurotrophic factor trigger self-aggregated amyloid β-induced neuronal cell death in an Alzheimer’s cell model. Biological and Pharmaceutical Bulletin, 43(7), 1073-1080, 2020. doi: 10.1248/bpb.b20-00082.(IF=1.540, CiteScore=1.77 in 2018) # equally contribution.
  6. ＊Fumiaki Uchiumi, Yoko Ogino, Akira Sato, Sei-ichi Tanuma. Insights into the development of effective materials to suppress replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  AIMS Bioengineering, 7(3), 124-129, 2020. doi: 10.3934/bioeng.2020012. Short communication
  7. ＊Fumiaki Uchiumi, Akira Sato, Masashi Asai, Sei-ichi Tanuma. An NAD+ dependent/sensitive transcription system: Toward a novel anti-cancer therapy. AIMS Molecular Science, 7(1) 12-28, 2020. doi: 10.3934/molsci.2020002. Review article
  8. ＊Akira Sato, Yoko Ogino, Akira Shimotsuma, Akiko Hiramoto, Hye-Sook Kim, Yusuke Wataya. Direct interaction analysis of microRNA-351-5p and nuclear scaffold lamin B1 mRNA by the cell-free in vitro mRNA/miRNA binding evaluation system. Nucleosides, Nucleotides and Nucleic Acids, 39(6), 799-805, 2020. doi: 10.1080/15257770.2019.1702675. (IF=1.556, CiteScore=2.2 in 2019)

2019

  1. Mana Inada, ＊Akira Sato, Mika Shindo, Yohei Yamamoto,  Yasuharu Akasaki, Koichi Ichimura, Sei-ichi Tanuma. Anti-cancer non-narcotic opium alkaloid papaverine suppresses human glioblastoma cell growth. Anticancer Research, 39(12), 6743-6750, 2019. doi: 10.21873/anticanres.13889. (IF=1.935, CiteScore=1.90 in 2018)
  2. Yoko Ogino, ＊Akira Sato, Yohei Kawano, Takao Aoyama, Fumiaki Uchiumi, Sei-ichi Tanuma. Association of ABC transporter with resistance to FK866, a NAMPT inhibitor, in human colorectal cancer cells. Anticancer Research, 39(12), 6457-6462, 2019. doi: 10.21873/anticanres.13859. (IF=1.935, CiteScore=1.90 in 2018)
  3. Yoko Ogino, ＊Akira Sato, Fumiaki Uchiumi, Sei-ichi Tanuma. Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells. Genomics, 111(6), 1889-1895, 2019. doi: 10.1016/j.ygeno.2018.12.012 (IF=6.205, CiteScore=5.50 in 2019)
  4. Hiroshi Hamada, Yuta Goto, Jun Arakawa, Erisa Murayama, Yui Ogawa, Midori Konno, Takahiro Oyama, Masashi Asai, Akira Sato, Sei-ichi Tanuma, ＊Fumiaki Uchiumi. Characterization of the human E2F4 promoter region and its response to 12-O-tetradecanoylphorbol-13-acetate. The Journal of Biochemistry, 166 (4), 363-373, 2019. doi: https://doi.org/10.1093/jb/mvz047 (IF=2.230, CiteScore=2.33 in 2018)
  5. ＊Takayuki Yamamoto, Akira Sato, Yusuke Takai, Atsushi Yoshimori, Masahiro Umehara, Yoko Ogino, Mana Inada, Nami Shimada, Aya Nishida, Risa Ichida, Ryoko Takasawa, Hiroko Maruki-Uchida, Sadao Mori, Masahiko Sai, Minoru Morita, ＊Sei-ichi Tanuma. Effect of piceatannol-rich passion fruitseed extract on human glyoxalase I-mediated cancer cell growth. Biochemistry and Biophysics Reports, 20, 100684, 2019. https://doi.org/10.1016/j.bbrep.2019.100684 (CiteScore=3.6 in 2019)
  6. Masayuki Morita, Kosuke Hayashi, Akira Sato, Akiko Hiramoto, Osamu Kaneko, Rena Isogawa, Yuji Kurosaki, Shin-ichi Miyoshi, Kyung-Soo Chang, Yusuke Wataya, ＊Hye-Sook Kim. Genomic and biological features of Plasmodium falciparum resistance against antimalarial endoperoxide N-89. Gene, 716, 144016, 2019. doi: https://doi.org/10.1016/j.gene.2019.144016 (IF=2.984, CiteScore=4.8 in 2019)
  7. Kazuaki Okada, Akira Sato, Akiko Hiramoto, Rena Isogawa, Yuji Kurosaki, ＊Kazutaka Higaki, Shin-Ichi Miyoshi, Kyung-Soo Chang, ＊Hye-Sook Kim. Pharmacokinetic analysis of new synthetic antimalarial N-251. Tropical Medicine and Health, 47:40, 2019. https://doi.org/10.1186/s41182-019-0167-4. (SJR=0.563, CiteScore=1.130 in 2017)
  8. Yasunobu Asawa, Kiyotaka Katsuragi, Akira Sato, Atsushi Yoshimori, ＊Sei-ichi Tanuma, ＊Hiroyuki Nakamura. Structure-based drug design of novel carborane-containing nicotinamide phosphoribosyltransferase inhibitors. Bioorganic & Medicinal Chemistry, 27(13), 2832-2844, 2019. doi: 10.1016/j.bmc.2019.05.013. (IF=3.073, CiteScore=5.5 in 2019)
  9. Mana Inada, Mika Shindo, Kyousuke Kobayashi, ＊Akira Sato, Yohei Yamamoto,  Yasuharu Akasaki, Koichi Ichimura, ＊Sei-ichi Tanuma. Anticancer effects of a non-narcotic opium alkaloid medicine papaverine in human glioblastoma cells. PLOS ONE, 14(5):e0216358, 2019. https://doi.org/10.1371/journal.pone.0216358 (IF=2.766, CiteScore=5.2 in 2019)
  10. Kenya Tamada, Shingo Nakajima, Natsumi Ogawa, Mana Inada, Hiroyuki Shibasaki, Akira Sato, Ryoko Takasawa, Atsushi Yoshimori, Yusuke Suzuki, Nobuo Watanabe, Takahiro Oyama, Hideaki Abe, Shigeaki, Inoue, Takehiko Abe, Takehiko Yokomizo, ＊Sei-ichi Tanuma. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses. Biochemical and Biophysical Research Communications, 511(3), 665-670, 2019. doi: 10.1016/j.bbrc.2019.01.136 (IF=2.985, CiteScore=4.60 in 2019)
  11. Hitoshi Tsugawa, Hideki Mori, Juntaro Matsuzaki, Akira Sato, Yoshimasa Saito, Masayo Imoto, Makoto Suematsu, ＊Hidekazu Suzuki. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy. Autophagy, 15(2), 242-258, 2019. doi:10.1080/15548627.2018.1515530. (IF=9.770, CiteScore=17.9 in 2019)
地域 千葉県野田市山崎２６４１ 東京理科大学薬学部１５号館３階 電話 04-7124-1501
search previous next tag category expand menu location phone mail time cart zoom edit close